While the precise role of these mutations in prostate cancer tumorigenesis requires further investigation into the precise mechanism, studies indicate that prostate tumors in patients with known MMR mutations often exhibit MMR deficiency, implying a role for germline alterations in predisposing individuals to prostate cancer [78,80]. The gene discussed is MRC1; the disease is prostate carcinoma.